[1]
|
P. T. Cardew, R. J. Davey and A. J. Ruddick, “Kinetics of Polymorphic Solid-State Transformation,” Journal of the Chemical Society, 80, No. 6, 1984, pp. 659-668.
|
[2]
|
R. J. Davey, P. T. Cardew, D. McEwan and D. E. Sadler, “Rate Controlling Processes in Solvent-Mediated Phase Transformations,” Journal of Crystal Growth, Vol. 79, No. 1-3, 1986, pp. 648-653.
doi:10.1016/0022-0248(86)90532-4
|
[3]
|
S. Rohani, S. Horne and K. Murthy, “Control of Product Quality in Batch Crystallization of Pharmaceuticals and Fine Chemicals, Part 1: Design of the Crystallization Process and the Effect of Solvent,” Organic Process Research & Development, Vol. 9, 2005, pp. 858-872.
doi:10.1021/op050049v
|
[4]
|
R. Hilfiker, “Polymorphism: In the Pharmaceutical Industry,” Weinheim, Wiley-VCH, 2006.
doi:10.1002/3527607889
|
[5]
|
A. Caillet, N. Sheibat-Othman and G. Fevotte, “Crystallization of Mono-hydrate Citric Acid. 2. Modeling through Population Balance Equations,” Crystal Growth & Design, Vol. 7, No. 10, 2007, pp. 2088-2095.
doi:10.1021/cg0606343
|
[6]
|
M. W. Hermanto, C. K. Nicholas, B. H. Reginald, C. M. Tan and R. Braatz, “Robust Bayesian Estimation of Kinetics for the Polymorphic Transformation of L-Glutamic Acid Crystals,” AIChE Journal, Vol. 54, No. 12, 2008, pp. 3248-3259. doi:10.1002/aic.11623
|
[7]
|
J. Sch?ll, D. Bonalumi, L. Vicum, M. Mazzotti and M. Müller, “In Situ Monitoring and Modeling of the Solvent-Mediated Polymorphic Transformation of L-Glutamic Acid,” Crystal Growth & Design, Vol. 6, No. 4, 2006, pp. 881-891. doi:10.1021/cg0503402
|
[8]
|
H. Qu, H. Alatalo, J. Kohonen, M. Louhi-Kultanen, S. Reinikainen and J. Kallas, “Raman and ATR FTIR Spectroscopy in Reactive Crystallization: Simultaneous Monitoring of Solute Concentration and Polymorphic State of the Crystals,” Journal of Crystal Growth, Vol. 311, 2009, pp. 3466-3475. doi:10.1016/j.jcrysgro.2009.04.018
|
[9]
|
H. Gr?n, A. Borissava and K.J. Roberts, “In-Process ATR-FTIR Spectroscopy for Closed-Loop Supersaturation Control of a Batch Crystallizer Producing Monosodium Glutamate Crystals of Defined Size,” Industrial & Engineering Chemistry Research, Vol. 42, No. 1, 2003, pp. 198-206. doi:10.1021/ie020346d
|
[10]
|
M. W. Hermanto, R. D. Braatz and M. Chiu, “A Run-to- Run Control Strategy for Polymorphic Transformation in Pharmaceutical Crystallization,” IEEE Proceedings, Munich, 2006, pp. 2121-2126.
|
[11]
|
M. Trifkovic, M. Sheikhzadeh and S. Rohani, “Multivariable Real-Time Optimal Control of a Cooling and Semibatch Crystallization Process,” AIChE Journal, Vol. 55, No. 10, 2009, pp. 2591-2602. doi:10.1002/aic.11868
|
[12]
|
A. Caillet, F. Puel and G. Fevotte, “In-Line Monitoring of Partial and Overall Solid Concentration during Solvent-Mediated Phase Transition Using Raman Spectroscopy,” International Journal of Pharmaceutics, Vol. 307, No. 2, 2006, pp. 201-207. doi:10.1016/j.ijpharm.2005.10.009
|
[13]
|
B. O’Sullivan, P. Barrett, G. Hsiao and A. Carr, “Glennon, B. In-Situ Monitoring of Polymorphic Transformation,” Organic Process Research & Development, Vol. 7, 2003, pp. 977-982. doi:10.1021/op030031p
|
[14]
|
H. Qu, M. Louhi-Kultanen, J. Rantanen and J. Kallas, “Solvent-Mediated Phase Transformation Kinetics of an Anhydrate/Hydrate System,” Crystal Growth & Design, Vol. 6, 2006, pp. 2053-2060. doi:10.1021/cg0600593
|
[15]
|
Y. Hu, J. K. Liang, A. S. Myer-son and L. S. Taylor, “Crystallization Monitoring by Raman Spectroscopy: Simultaneous Measurement of Desupersaturation Profile and Polymorphic Form in Flufenamic Acid Systems,” Industrial & Engineering Chemistry Research, Vol. 44, 2005, pp. 1233-1240. doi:10.1021/ie049745u
|
[16]
|
T. Ono, J. H. Horst and P. J. Jansens, “Quantitative Measurement of the Polymorphic Transformation of L-Glutamic Acid Using in-Situ Raman Spectroscopy,” Crystal Growth & Design, Vol. 4, 2004, pp. 465-469.
doi:10.1021/cg0342516
|
[17]
|
G. Fevotte, “In Situ Raman Spec-troscopy for In-Line Control of Pharmaceutical Crystallization and Solids Elaboration Processes: A Review,” Chemical Engineering Research and Design, Vol. 85, No. A7, 2007, pp. 906- 926. doi:10.1205/cherd06229
|
[18]
|
M. Sheikhzadeh, S. Murad and S. Rohani, “Response Surface Analysis of Solution-Mediated Polymorphic Trans- formation of Buspirone Hy-drochloride,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 45, No. 2, 2007, pp. 227-236. doi:10.1016/j.jpba.2007.06.001
|
[19]
|
M. Sheikhzadeh, S. Rohani, A. Jutan, T. Manifar, K. Murthy and S. Horne, “Solid-State Characterization of Buspirone Hydrochloride Poly-morphs,” Pharmaceutical Research, Vol. 23, No. 5, 2006, pp. 1043-1050.
doi:10.1007/s11095-006-9779-6
|
[20]
|
A. D. Randolph and M. A. Larson, “Theory of Particulate Processes,” Academic Press, New York, 1988.
|
[21]
|
Q. Hu, S. Rohani and A. Jutan, “Modeling and Optimization of Batch Seeded Cooling Crystallizers,” Computers & Chemical Engineering, Vol. 29, No. 4, 2005, pp. 911- 918. doi:10.1016/j.compchemeng.2004.09.011
|
[22]
|
A. Mersmann, “Crystallization Technology Handbook,” Marcell Dekker Inc., New York, 2001.
doi:10.1201/9780203908280
|
[23]
|
J. Cornel, C. Lindenberg and M. Mazzotti, “Experimental Characterization and Population Balance Modleing of the Polymorph Transformation of l-Glutamic Acid,” Crystal Growth & Design, Vol. 9, No. 1, 2009, pp. 243-252.
doi:10.1021/cg800387a
|